About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
How I Treat Mantle Cell Lymphoma in 2020: Induction Options, ASCT, and Combining Targeted Agents in Relapse/Refractory
By
7th Eurasian Hematology Oncology Summit
FEATURING
Charles A. Schiffer
By
7th Eurasian Hematology Oncology Summit
FEATURING
Charles A. Schiffer
686 views
July 24, 2020
1 Comment
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
10:27
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…
Feat.
J. DiPersio
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
31:12
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
Feat.
S. Smith
37:44
University of Colorado Division of Hematology
Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas
Feat.
M. Kamdar
04:34
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Highlights and Key Takeaways in MCL"
Feat.
P. Jain
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
26:58
Total Health
Update on Cellular Therapy in Lymphoma
Feat.
B. Randolph
16:05
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is High Risk MCL and How Should We Treat It
Feat.
A. Kumar
06:43
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…
Feat.
V. Yazbeck
07:22
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Hypertension in Pts With CLL and Other Heme…
Feat.
A. Ferrajoli
05:24
Chan Cheah
Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Addi…
05:28
GRACE
3L Treatment for Mantle Cell Lymphoma
Feat.
T. Phillips
12:54
The University of Alabama at Birmingham School of Medicine
Tips and Tricks in Treatment of MCL: Choice of Regimens and Dosing C…
Feat.
M. Narkhede
44:19
University of Colorado Division of Hematology
Mantle Cell Lymphoma: Challenges & Prospects
Feat.
J. Jasem
06:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Pirtobrutinib in cBTKi Pre-Treated MCL - …
Feat.
N. Shah
04:13
GRACE
The TRIANGLE Study: Ibrutinib Maintenance for MCL
Feat.
T. Phillips
07:47
PrecisCa
Treatment Approach for Older Patients With Mantle Cell Lymphoma: A D…
Feat.
M. Kamdar
14:51
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Is Stem Cell Transplantation Still Necessary in Frontline…
Feat.
T. Fenske
08:19
ASH 2022 Conference Coverage
ASH 2022 Results From the Phase 1/2 BRUIN Study: Safety & Tolera…
Feat.
N. Shah
